SciELO - Scientific Electronic Library Online

 
vol.62 issue6Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindoprilPrognosis and bone marrow recovery indicators in bone marrow transplantation after total body irradiation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Medicina (Buenos Aires)

Print version ISSN 0025-7680On-line version ISSN 1669-9106

Abstract

CIACCIO, M.; MONTIVEROS, C.; RIVAROLA, M. A.  and  BELGOROSKY, A.. Effect of the dose of oral Hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia. Medicina (B. Aires) [online]. 2002, vol.62, n.6, pp.551-554. ISSN 0025-7680.

The effect of  the dose of oral  hydrocortisone on stature growth rate  of patients with the salt losing form of congenital adrenal hyperplasia and adequate electrolyte balance was here assessed. Thirty patients (21 girls and 9 boys) were followed longitudinally for 0.52 to 8.64 years, between chronological ages 0.35 and 8.64 years. Nine consecutive periods (Ps) of follow up were defined in order to compare two auxological parameters, height (H) at the end of a follow up P and DH standard deviation score (SDS). According to growth rate during a particular P, two types of Ps were defined: Ps with DH SDS > -0.5 (Group 1, satisfactory growth rate) and Ps with DH SDS = or < -0.5 (Group 2, poor growth rate). A cut off value of 18.5 mg/m2/day of oral hydrocortisone (95% CI upper limit of group 1) was defined to separate acceptable from excessive doses. In P2, mean (± SD) H SDS (-1.81 ± 1.15) was significantly lower than in any of the other Ps (p < 0.001). In P1 and in P2, DH SDS was negative, but it was positive in P3 and in P4. Hydrocortisone dose in P1 and in P2 was significantly higher than in the rest of the Ps. All patients in P1 and most patients in P2 , but not in other Ps, received excessive doses. Predicted adult H, calculated in 9 patients was not statistically different from their respective target H. It is concluded that, during the first year of life, our patients received an excess of oral hydrocortisone (> 18 mg/m2/day) and grew poorly, but they were able to recover, at least temporarily, when the dose was adjusted during the following years.

Keywords : Hydrocortisone dose; Congenital adrenal hyperplasia; Growth rate under  corticoids.

        · abstract in Spanish     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License